ENTITY
3D Medicines

3D Medicines (1244 HK)

25
Analysis
Health Care • China
3D Medicines Inc. operates as a commercial-stage biopharmaceutical company. The Company focuses on the development of differentiated immuno-oncology drugs. 3D Medicines conducts businesses in China.
more
Exchange Announcement • 02 Oct 2026 12:20

Change Of Principal Share Registrar And Transfer Office

Exchange Announcement • 30 Sep 2026 22:31

Interim Report 2026

Exchange Announcement • 17 Sep 2026 16:59

Discloseable Transaction

Exchange Announcement • 31 Aug 2026 22:50

Interim Results Announcement For The Six Months Ended June 30, 2026

Exchange Announcement • 28 Aug 2026 21:34

Change Of Address Of Registered Office

x